Smith Karen L. insider trades
Smith Karen L. has filed 23 Form 4s with the SEC that we hold, for Skye Bioscience, Inc. (SKYE) (Director), Sangamo Therapeutics, INC (SGMO) (Director), Aurinia Pharmaceuticals Inc. (AUPH) (Director) and Context Therapeutics Inc. (CNTX) (Director), among 8 companies in all. Across all of them we count 0 purchases worth $0 and 1 sale worth $44.2K reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a sale of 5,241 shares of Aurinia Pharmaceuticals Inc. worth $44.2K, dated 2024-11-11. The first filing on our record is dated 2021-11-22 and the latest 2026-06-26.
Skye Bioscience, Inc. (SKYE)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Sangamo Therapeutics, INC (SGMO)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Aurinia Pharmaceuticals Inc. (AUPH)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2024-11-11 | S, sale reported on Form 4 | 5,241 | $44.2K | 2024-11-12 |
Context Therapeutics Inc. (CNTX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Quince Therapeutics, Inc. (QNCX)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
TALS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
ATRS
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
XLRN
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1639637) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms